Audentes Therapeutics is a startup based in the United States, most recent round Acquired.
Based in the United States, Audentes Therapeutics is a startup. Audentes Therapeutics has been acquired.
Audentes Therapeutics was a biotechnology company developing AAV-based gene therapies targeting rare neuromuscular diseases. The company advanced gene-replacement programs for inherited disorders and was acquired by Astellas Pharma in 2019.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.